CD30 Expression and Its Correlation with Clinicopathologic Features in Indonesian Diffuse Large B-Cell Lymphoma
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype (68.2%) of B cells Non Hodgkin Lymphoma in Indonesia. This tumor heterogeneity is characterized by a variety of clinical conditions, morphology, genetic profiles, therapeutic response, prognosis and survival. Recent studies...
Main Authors: | Maria Reynelda Santoso, Mardiah Suci Hardianti, Indrawati Indrawati, Nungki Anggorowati |
---|---|
Format: | Article |
Language: | English |
Published: |
West Asia Organization for Cancer Prevention
2020-09-01
|
Series: | Asian Pacific Journal of Cancer Biology |
Subjects: | |
Online Access: | http://www.waocp.com/journal/index.php/apjcb/article/view/471 |
Similar Items
-
Sociodemographic and Clinicopathological Features of Lymphoma Patients in Indonesia: A report from Special Region of Yogyakarta Province
by: Nungki Anggorowati, et al.
Published: (2022-01-01) -
DIFFUSE LARGE B-CELL LYMPHOMA OF THE HEART
by: Faizah Dwi Tirtasari, et al.
Published: (2022-05-01) -
Clinicopathologic characteristics, gene mutation profile and prognostic analysis of thyroid diffuse large B-cell lymphoma
by: DU Zhishan, et al.
Published: (2024-01-01) -
Primary CD20‐positive mediastinal diffuse large B‐cell lymphoma
by: Wulyo Rajabto, et al.
Published: (2020-11-01) -
Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
by: Wei Sang, et al.
Published: (2020-08-01)